T45.623
Poisoning by hemostatic drug, assault
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by hemostatic drugs, classified under ICD-10 code T45.623, refers to adverse health effects resulting from the misuse, overdose, or toxic exposure to medications used to promote blood clotting. Hemostatic agents are vital in controlling bleeding; however, accidental or intentional poisoning can lead to serious health consequences. Recognizing the causes, symptoms, and treatment options is essential for healthcare providers, patients, and caregivers to manage such situations effectively.
Causes & Symptoms
Clinical Causes: Overdose of hemostatic medications, either accidental or intentional Misuse or incorrect administration of hemostatic agents Ingestion of contaminated or improperly labeled products Intentional poisoning through assault involving hemostatic drugs Interaction with other medications leading to toxicity Lack of proper storage and handling of these drugs, leading to accidental ingestion
Key Symptoms: Unusual bleeding or bleeding that does not stop easily Signs of internal bleeding such as abdominal pain, dizziness, or weakness Nausea and vomiting Sudden and severe headache Changes in blood pressure, either high or low Coughing up blood Dark or tarry stools indicating gastrointestinal bleeding Signs of allergic reaction like rash, itching, swelling, or difficulty breathing in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical history review, including possible exposure or ingestion of hemostatic drugs. Laboratory tests such as blood clotting profiles (PT, aPTT), complete blood count (CBC), and drug levels may be performed to assess the extent of poisoning. Toxicology screens can help identify the specific substance involved. Imaging studies might be necessary if internal bleeding is suspected. Accurate documentation and assessment are essential for guiding treatment strategies.
Treatment Protocols: Management of poisoning by hemostatic drugs generally includes supportive care and specific interventions tailored to the severity of the condition. These may involve: - Stabilizing vital signs and ensuring airway, breathing, and circulation are maintained. - Discontinuing the suspected offending medication. - Administering activated charcoal if the poisoning is recent to limit drug absorption. - Use of specific antidotes if available and applicable. - Performing blood transfusions or plasma exchange in cases of severe bleeding or overdose. - Monitoring blood clotting parameters regularly. - Providing supportive therapies, including IV fluids and medications to control bleeding and stabilize blood pressure. - Psychological or psychiatric support may be necessary if the poisoning is intentional or related to misuse. It's important to seek immediate medical attention if poisoning is suspected to ensure appropriate interventions and prevent complications.
Clinical Advice & FAQs
Billing Guidance
Is T45.623 a billable ICD-10 code?
Yes, T45.623 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.623?
Clinical documentation must specify the nature of Poisoning by hemostatic drug, assault and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
